XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.1
License Agreements - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Jul. 31, 2022
Research And Development Arrangement Contract To Perform For Others [Line Items]        
Research and development expenses $ 47,110 $ 24,490    
Common stock shares issued 61,863,010   61,730,816 1,519,756
Issuance of common stock, value $ 62   $ 62  
Harvard and Board        
Research And Development Arrangement Contract To Perform For Others [Line Items]        
Success payment liability 300      
Payment of milestone development 23,100      
Payment of sales based milestone 54,000      
Beam License Agreement        
Research And Development Arrangement Contract To Perform For Others [Line Items]        
Research and development expenses 0 $ 0    
Novartis license agreement [Member]        
Research And Development Arrangement Contract To Perform For Others [Line Items]        
Payment of sales based milestone 35,000      
Clinical And Regulatory Milestone 10,000      
Milestone related expenses $ 0